Which major pharmaceutical company will Generate:Biomedicines announce a new partnership with by September 30, 2025? | Categorical | | | 3 months ago | |
Will Generate:Biomedicines initiate a clinical trial for a new protein therapeutic from the Novartis partnership by March 31, 2025? | Binary | | | 3 months ago | |
Will Novartis make an additional milestone payment to Generate:Biomedicines by December 31, 2024? | Binary | | | 3 months ago | |
Will Generate:Biomedicines' cash balance exceed $400 million by March 31, 2025? | Binary | | | 3 months ago | |
Will GSK increase its initial investment in the Flagship Pioneering collaboration by June 30, 2025? | Binary | | | 5 months ago | |
Will at least one drug from the Flagship Pioneering and GSK collaboration receive FDA approval by December 31, 2025? | Binary | | | 5 months ago | |
What will be the outcome of the first clinical data from the Novartis and Generate:Biomedicines partnership reported by December 31, 2024? | Categorical | | | 3 months ago | |
What will be the first disease area targeted by the Novartis and Generate:Biomedicines partnership announced by June 30, 2025? | Categorical | | | 3 months ago | |
What type of candidate from the Flagship Pioneering and GSK collaboration will enter clinical trials first by December 31, 2024? | Categorical | | | 5 months ago | |
How many drugs or vaccines will be developed under the Flagship Pioneering and GSK collaboration by December 31, 2025? | Categorical | | | 5 months ago | |
How much additional funding will GSK commit to the Flagship Pioneering collaboration by December 31, 2025? | Categorical | | | 5 months ago | |
